GYL Financial Synergies LLC Purchases New Shares in AMBEV S A/S (NYSE:ABEV)

GYL Financial Synergies LLC bought a new position in shares of AMBEV S A/S (NYSE:ABEV) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 14,620 shares of the company’s stock, valued at approximately $63,000.

Several other large investors have also bought and sold shares of the company. Rehmann Capital Advisory Group grew its position in AMBEV S A/S by 141.0% in the 4th quarter. Rehmann Capital Advisory Group now owns 8,800 shares of the company’s stock worth $34,000 after purchasing an additional 5,148 shares in the last quarter. Enterprise Financial Services Corp bought a new position in shares of AMBEV S A/S during the 1st quarter valued at approximately $43,000. Paloma Partners Management Co bought a new position in shares of AMBEV S A/S during the 4th quarter valued at approximately $45,000. Alta Capital Management LLC purchased a new stake in shares of AMBEV S A/S during the 1st quarter valued at approximately $46,000. Finally, South Texas Money Management Ltd. purchased a new stake in shares of AMBEV S A/S during the 1st quarter valued at approximately $47,000. 7.32% of the stock is owned by institutional investors.

Shares of ABEV stock traded down $0.11 on Friday, hitting $4.84. 50,633,779 shares of the company’s stock traded hands, compared to its average volume of 23,987,620. The stock has a market cap of $76.09 billion, a PE ratio of 25.47, a price-to-earnings-growth ratio of 4.85 and a beta of 0.70. AMBEV S A/S has a one year low of $3.77 and a one year high of $5.44. The company has a quick ratio of 0.87, a current ratio of 1.13 and a debt-to-equity ratio of 0.08. The firm’s fifty day moving average is $4.64.

AMBEV S A/S (NYSE:ABEV) last announced its quarterly earnings results on Tuesday, May 7th. The company reported $0.04 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.01). AMBEV S A/S had a return on equity of 19.60% and a net margin of 21.99%. The firm had revenue of $3.09 billion during the quarter, compared to the consensus estimate of $3.37 billion. As a group, equities research analysts anticipate that AMBEV S A/S will post 0.2 EPS for the current year.

Several analysts have issued reports on the stock. Zacks Investment Research upgraded shares of Investar from a “hold” rating to a “buy” rating and set a $27.00 target price on the stock in a research note on Tuesday, June 4th. Bank of America reiterated an “underperform” rating and issued a GBX 55 ($0.72) target price on shares of Lloyds Banking Group in a research note on Tuesday, May 21st. ValuEngine lowered shares of Intersect ENT from a “buy” rating to a “hold” rating in a report on Monday, July 8th. Finally, TheStreet lowered shares of Trinseo from a “b-” rating to a “c+” rating in a report on Friday, May 17th. Four analysts have rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the company’s stock. AMBEV S A/S presently has a consensus rating of “Hold” and an average price target of $5.33.

AMBEV S A/S Company Profile

Ambev SA, through its subsidiaries, produces, distributes, and sells beer, draft beer, carbonated soft drinks (CSD), other non-alcoholic beverages, malt, and food products in the Americas. It operates through three segments: Latin America North, Latin America South, and Canada. The company offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Brahva Gold, Extra, Budweiser, Bud Light, Stella Artois, Corona, Modelo Especial, Beck, Leffe, Hoegaarden, Presidente, Brahma Light, President Light, Bohemia, The One, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Báltica, Ouro Fino, Pilsen, Patricia, Labatt Blue, Alexander Keith's, Kokanee, Banks, and Deputy brands.

Featured Article: Quiet Period

Institutional Ownership by Quarter for AMBEV S A/S (NYSE:ABEV)

Receive News & Ratings for AMBEV S A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMBEV S A/S and related companies with MarketBeat.com's FREE daily email newsletter.